Key Highlights from the Pressure Ulcer Market Report

The pressure ulcer market is projected to grow across the seven major markets (7MM) during the study period.
The incidence of pressure ulcers is notably higher among individuals with diabetes, with the global prevalence of diabetes estimated at 537 million cases in adults. Approximately 150 million of these individuals are expected to experience ulcers at some point.
Studies suggest that 10% of the U.S. population will encounter pressure ulcers in their lifetime.
The market is set to surge due to the increasing prevalence of pressure ulcers and heightened awareness, along with the introduction of various pipeline products that could transform market dynamics.

Get a free sample of “Pressure Ulcer Market Report”

Country-Based Treatment Analysis

The report provides valuable treatment regimen analyses across the 7MM, helping companies understand regional practices, the patient journey, and innovations in pressure ulcer therapies. This understanding is crucial for identifying opportunities to improve treatment outcomes.

Understanding Pressure Ulcers

Pressure ulcers, commonly known as bedsores, are localized injuries to the skin and underlying tissue caused by prolonged pressure. They typically occur in individuals who are bedridden, wheelchair-bound or have limited mobility, usually forming over bony areas like the heels, hips, tailbone, and elbows. The development of these ulcers can be attributed to factors such as pressure intensity, duration, and the overall health of the individual. Insufficient blood flow to affected areas can lead to tissue damage, resulting in pain, open wounds, and severe complications like infections.

Preventing pressure ulcers involves strategies such as regular repositioning, maintaining proper nutrition, utilizing specialized support surfaces, and ensuring effective skincare. Early detection and appropriate management are crucial for preventing ulcer progression and promoting healing. Healthcare professionals implement tailored treatments, including wound care, infection control, and pressure redistribution techniques.

Get a free sample of “Pressure Ulcer Market Report”

Epidemiology Insights

The report offers historical and projected epidemiological insights that illuminate the target patient population for pressure ulcers from 2019 to 2032. This analysis enables companies to understand patient trends that will shape market dynamics, including segmentation based on the total prevalence of pressure ulcers, severity, gender-specific prevalence, and the classification of diagnosed cases.

Emerging Therapies and Market Forecast

The report highlights emerging therapies like EGT 022 from EyeGene, a recombinant polypeptide designed to aid wound healing, along with other promising treatments. Recent advancements include:

In March 2021, Smith and Nephew reported a real-world study showing that the switch to ALLEVYN LIFE Foam Dressings significantly reduced dressing change frequency and costs while improving clinician and patient satisfaction.
In February 2021, Axis Biosolutions received CE mark approval for MAxiCel, a product aimed at treating chronic wounds, including pressure ulcers.

The research underscores anticipated market shifts due to the expected launch of new therapies such as Thymosin Beta 4 and Ibuprofen between 2019 and 2032. The rising prevalence of pressure ulcers, coupled with low competition for upcoming therapies, positions stakeholders for significant opportunities in this evolving market.

Strategic Insights for Stakeholders

DelveInsight’s report equips stakeholders with comprehensive insights, market analysis, and forecasts, aiding in strategic decision-making. Key considerations include identifying market gaps and opportunities, understanding the competitive landscape, and developing tailored strategies for product development and market penetration.

With a roadmap informed by these insights, pressure ulcer companies can set short-term and long-term goals, define effective strategies, and navigate the complexities of the pressure ulcer market with clarity.

About DelveInsight

DelveInsight is a prominent healthcare business consultant and market research firm focused exclusively on life sciences. The company supports pharmaceutical firms with end-to-end solutions aimed at enhancing performance and offers healthcare consulting services that provide market analysis to drive business growth and address challenges effectively.

Latest Reports